285 related articles for article (PubMed ID: 36789748)
1. Autophagy and its role in osteosarcoma.
Ning B; Liu Y; Huang T; Wei Y
Cancer Med; 2023 Mar; 12(5):5676-5687. PubMed ID: 36789748
[TBL] [Abstract][Full Text] [Related]
2. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma.
Liao YX; Yu HY; Lv JY; Cai YR; Liu F; He ZM; He SS
Int J Oncol; 2019 Dec; 55(6):1213-1222. PubMed ID: 31638211
[TBL] [Abstract][Full Text] [Related]
3. Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy.
Jamali Z; Taheri-Anganeh M; Shabaninejad Z; Keshavarzi A; Taghizadeh H; Razavi ZS; Mottaghi R; Abolhassan M; Movahedpour A; Mirzaei H
IUBMB Life; 2020 Jul; 72(7):1306-1321. PubMed ID: 32233112
[TBL] [Abstract][Full Text] [Related]
4. Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment.
Li J; Yang Z; Li Y; Xia J; Li D; Li H; Ren M; Liao Y; Yu S; Chen Y; Yang Y; Zhang Y
Oncotarget; 2016 Jul; 7(28):44763-44778. PubMed ID: 27007056
[TBL] [Abstract][Full Text] [Related]
5. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
6. Non‑covalent proteasome inhibitor PI‑1840 induces apoptosis and autophagy in osteosarcoma cells.
Chen Y; Chen H; Xie H; Yuan S; Gao C; Yu L; Bi Z
Oncol Rep; 2019 May; 41(5):2803-2817. PubMed ID: 30864717
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
8. Osteosarcoma: Conventional treatment vs. gene therapy.
Tan ML; Choong PF; Dass CR
Cancer Biol Ther; 2009 Jan; 8(2):106-17. PubMed ID: 19098456
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma treatment: state of the art.
Ta HT; Dass CR; Choong PF; Dunstan DE
Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
[TBL] [Abstract][Full Text] [Related]
10. mTOR: An attractive therapeutic target for osteosarcoma?
Ding L; Congwei L; Bei Q; Tao Y; Ruiguo W; Heze Y; Bo D; Zhihong L
Oncotarget; 2016 Aug; 7(31):50805-50813. PubMed ID: 27177330
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective role of autophagy during paclitaxel-induced apoptosis in Saos-2 osteosarcoma cells.
Kim HJ; Lee SG; Kim YJ; Park JE; Lee KY; Yoo YH; Kim JM
Int J Oncol; 2013 Jun; 42(6):1985-92. PubMed ID: 23563171
[TBL] [Abstract][Full Text] [Related]
12. Effects of butein on human osteosarcoma cell proliferation, apoptosis, and autophagy through oxidative stress.
Zhang P; Zhang J; Quan H; Chen P; Wang J; Liang Y
Hum Exp Toxicol; 2022; 41():9603271221074346. PubMed ID: 35130734
[TBL] [Abstract][Full Text] [Related]
13. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
[TBL] [Abstract][Full Text] [Related]
14. The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
Mukherjee S; Dash S; Lohitesh K; Chowdhury R
PLoS One; 2017; 12(6):e0179203. PubMed ID: 28598976
[TBL] [Abstract][Full Text] [Related]
15. [Recent aspects of osteosarcoma therapy].
Hoffken K; Schmidt CG
Dtsch Med Wochenschr; 1976 Feb; 101(7):251-8. PubMed ID: 765088
[No Abstract] [Full Text] [Related]
16. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
17. [Recent advances in the treatment of childhood osteosarcoma: therapeutic modalities at the M.D. Anderson Hospital and Tumor Institute].
Takaue Y; Jaffe N
Gan To Kagaku Ryoho; 1987 Jan; 14(1):38-43. PubMed ID: 3467656
[TBL] [Abstract][Full Text] [Related]
18. [Results of treatment for osteosarcoma in children and youth].
Nurzyńska-Flak J; Katski K; Zawitkowska-Klaczyńska J; Mazurkiewicz T; Kowalczyk JR
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1037-40. PubMed ID: 15951598
[TBL] [Abstract][Full Text] [Related]
19. The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models.
Zhu YR; Zhou XZ; Zhu LQ; Yao C; Fang JF; Zhou F; Deng XW; Zhang YQ
Oncotarget; 2016 Aug; 7(31):49527-49538. PubMed ID: 27385099
[TBL] [Abstract][Full Text] [Related]
20. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal.
Li S; Sun W; Wang H; Zuo D; Hua Y; Cai Z
Tumour Biol; 2015 Mar; 36(3):1329-38. PubMed ID: 25666750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]